IDEXX (IDXX) Bets an AI Scribe Can Sell More Pet Diagnostics

insidermonkey.com · 2026-09-19

On September 16, IDEXX Laboratories (NASDAQ:IDXX) announced it had bought CoVetAI, a fast-growing veterinary software company whose tool listens during appointments and organizes what gets said and done...

TickrTrends take: IDEXX is pursuing an artificial intelligence scribe tool as a growth driver within its pet diagnostics business, a strategy that could enhance operational efficiency and sales capacity if successfully adopted by veterinary clinics. Given TickrTrends' current undervalued assessment, investors should monitor whether this AI investment translates into meaningful revenue expansion and margin improvements that would justify the technology's development costs. The Healthcare sector's competitive dynamics around AI-driven solutions mean that execution on this initiative may become a differentiator in how the market reprices the company's growth prospects.

Read the full story at insidermonkey.com →